pRospective Evaluation of Clinical Outcomes in Patients With metAsTatIс melanOma Treated With dabrafeNib and trAmetinib in reaL practicE
Clinical trial NCT05171374 · UNKNOWN
Trial details
- NCT number
- NCT05171374
- Sponsor
- MelanomaPRO, Russia
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-30
- Primary completion
- 2023-09-30
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.